Sinovac Biotech(SVA)
$6.470.00 (0.00%)
SVA
Sinovac Biotech Revenue
$6.47
At close:0.00 (0.00%)
Want to see SVA full AI Analyst Report?
Sinovac Biotech (SVA) Revenue
137 Followers
Sinovac Biotech Revenue
Sinovac Biotech had a revenue of 307.87M in the quarter ending Dec 31, 2023, with 119.27%. This bring the company's revenue in the last twelve months to 448.27M, Increased 6.51%. In the fiscal year ending Dec 31, 2025, Sinovac Biotech had annual revenue of 386.01M with 6.82% growth.
- Revenue (ttm)
- 448.27M
- Revenue Growth
- 8.78%
- P/S Ratio
- 1.19
- Revenue/Employee
- $197,046
- Employees
- 1,959
- Market Cap
- $460.27M
Revenue Chart
Sinovac Biotech Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 386.01M | 24.64M | 6.82% |
| Dec 31, 2024 | 361.37M | -86.89M | -19.38% |
| Dec 31, 2023 | 448.27M | -1.04B | -69.97% |
| Dec 31, 2022 | 1.49B | -17.88B | -92.30% |
| Dec 31, 2021 | 19.37B | 18.86B | 3694.36% |
| Dec 31, 2020 | 510.62M | 264.57M | 107.53% |
| Mar 31, 2020 | 246.05M | 16.40M | 7.14% |
| Mar 31, 2019 | 229.65M | 55.30M | 31.72% |
| Dec 31, 2017 | 174.35M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.